Hyaluronidase should not be used to enhance the dispersion and absorption of alpha agonist drugs.
Source: NLP:hyaluronidase
8 interactions on record
Hyaluronidase should not be used to enhance the dispersion and absorption of alpha agonist drugs.
Source: NLP:hyaluronidase
Concomitant use can cause significant additive blood pressure reduction leading to symptomatic hypotension (dizziness, lightheadedness, fainting). Caution is advised when co-administered.
Source: NLP:avanafil
Potential additive blood pressure-lowering effects. Initiate sildenafil at lowest dose after patients are stable on alpha-blocker therapy.
Source: NLP:sildenafil citrate
Pharmacodynamic interactions expected but not fully determined. Concomitant use is not recommended due to potential additive effects.
Source: NLP:silodosin
Caution advised when tadalafil is coadministered with alpha-blockers. Both are vasodilators with blood-pressure-lowering effects, resulting in additive hypotensive effects.
Source: NLP:tadalafil
Should not be used in combination with alfuzosin. Pharmacokinetic and pharmacodynamic interactions may be expected.
Source: NLP:alfuzosin hydrochloride
Antagonize peripheral vasoconstriction caused by high-dose dopamine but do not antagonize renal and mesenteric vasodilation.
Source: NLP:dopamine hydrochloride
Alpha-blockers may cause additive blood pressure-lowering effects with sildenafil; use caution and initiate sildenafil at lowest dose in stable patients.
Source: NLP:sildenafil